Top compounds associated with response to SRI


Feature Type Standardized
Nominal ANOVA
mRNA CHEMBL374350 CTRPv2 pan-cancer AAC -0.032 0.4
mRNA BRD-A02303741 CTRPv2 pan-cancer AAC -0.032 0.4
mRNA ABT-199 CTRPv2 pan-cancer AAC -0.036 0.4
mRNA Bleomycin GDSC1000 pan-cancer AAC -0.029 0.4
mRNA itraconazole CTRPv2 pan-cancer AAC -0.032 0.4
mRNA AG-014699 GDSC1000 pan-cancer AAC -0.028 0.4
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.4
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.03 0.4
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.028 0.4
mRNA OSI-906 CTRPv2 pan-cancer AAC -0.029 0.4
Download CSV